MedTrace Logo

To Evaluate the Safety and Performance of the ProstaCare Water Electrolysis System in Relieving Symptoms of BPH.

NCT02962674 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2021-10-15

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety and performance of the ProstaCare System in relieving symptoms of urinary outflow obstruction secondary to benign prostatic hyperplasia.

Conditions

  • Benign Prostatic Hyperplasia

Interventions

DEVICE

prostaFix System

Sponsors & Collaborators

  • ProstaCare Singapore Pte. Ltd.

    lead INDUSTRY

Principal Investigators

  • Henry Ho Sun Sien, MD · Singapore General Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-19
Primary Completion
2018-10-30
Completion
2020-11-20

Countries

  • New Zealand
  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02962674 on ClinicalTrials.gov